184 related articles for article (PubMed ID: 21464556)
1. Interest in genetic testing for modest changes in breast cancer risk: implications for SNP testing.
Graves KD; Peshkin BN; Luta G; Tuong W; Schwartz MD
Public Health Genomics; 2011; 14(3):178-89. PubMed ID: 21464556
[TBL] [Abstract][Full Text] [Related]
2. Interest and informational preferences regarding genomic testing for modest increases in colorectal cancer risk.
Anderson AE; Flores KG; Boonyasiriwat W; Gammon A; Kohlmann W; Birmingham WC; Schwartz MD; Samadder J; Boucher K; Kinney AY
Public Health Genomics; 2014; 17(1):48-60. PubMed ID: 24435063
[TBL] [Abstract][Full Text] [Related]
3. The impact of direct-to-consumer personal genomic testing on perceived risk of breast, prostate, colorectal, and lung cancer: findings from the PGen study.
Carere DA; VanderWeele T; Moreno TA; Mountain JL; Roberts JS; Kraft P; Green RC;
BMC Med Genomics; 2015 Oct; 8():63. PubMed ID: 26468061
[TBL] [Abstract][Full Text] [Related]
4. Personalized Medicine Through SNP Testing for Breast Cancer Risk: Clinical Implementation.
Howe R; Miron-Shatz T; Hanoch Y; Omer ZB; O'Donoghue C; Ozanne EM
J Genet Couns; 2015 Oct; 24(5):744-51. PubMed ID: 25519004
[TBL] [Abstract][Full Text] [Related]
5. Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing.
Lerman C; Biesecker B; Benkendorf JL; Kerner J; Gomez-Caminero A; Hughes C; Reed MM
J Natl Cancer Inst; 1997 Jan; 89(2):148-57. PubMed ID: 8998184
[TBL] [Abstract][Full Text] [Related]
6. Factors Associated with Interest in Gene-Panel Testing and Risk Communication Preferences in Women from BRCA1/2 Negative Families.
Flores KG; Steffen LE; McLouth CJ; Vicuña BE; Gammon A; Kohlmann W; Vigil L; Dayao ZR; Royce ME; Kinney AY
J Genet Couns; 2017 Jun; 26(3):480-490. PubMed ID: 27496122
[TBL] [Abstract][Full Text] [Related]
7. A qualitative study on Singaporean women's views towards breast cancer screening and Single Nucleotide Polymorphisms (SNPs) gene testing to guide personalised screening strategies.
Wong XY; Chong KJ; van Til JA; Wee HL
BMC Cancer; 2017 Nov; 17(1):776. PubMed ID: 29162038
[TBL] [Abstract][Full Text] [Related]
8. Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
Nelson HD; Pappas M; Cantor A; Haney E; Holmes R
JAMA; 2019 Aug; 322(7):666-685. PubMed ID: 31429902
[TBL] [Abstract][Full Text] [Related]
9. Making Sense of SNPs: Women's Understanding and Experiences of Receiving a Personalized Profile of Their Breast Cancer Risks.
Young MA; Forrest LE; Rasmussen VM; James P; Mitchell G; Sawyer SD; Reeve K; Hallowell N
J Genet Couns; 2018 Jun; 27(3):702-708. PubMed ID: 29168041
[TBL] [Abstract][Full Text] [Related]
10. Psychometric testing of the decisional conflict scale: genetic testing hereditary breast and ovarian cancer.
Katapodi MC; Munro ML; Pierce PF; Williams RA
Nurs Res; 2011; 60(6):368-77. PubMed ID: 22048556
[TBL] [Abstract][Full Text] [Related]
11. Interest in, willingness-to-pay for and willingness-to-recommend genetic testing for prostate cancer among affected men after radical prostatectomy.
Mayer M; Selig K; Tüttelmann F; Dinkel A; Gschwend JE; Herkommer K
Fam Cancer; 2019 Apr; 18(2):221-230. PubMed ID: 30229510
[TBL] [Abstract][Full Text] [Related]
12. Saudi women's interest in breast cancer gene testing: possible influence of awareness, perceived risk and socio-demographic factors.
Amin TT; Al-Wadaani HA; Al-Quaimi MM; Aldairi NA; Alkhateeb JM; Al-Jaafari AA
Asian Pac J Cancer Prev; 2012; 13(8):3879-87. PubMed ID: 23098487
[TBL] [Abstract][Full Text] [Related]
13. Women's interest in genetic testing for breast cancer risk: the influence of sociodemographics and knowledge.
Bottorff JL; Ratner PA; Balneaves LG; Richardson CG; McCullum M; Hack T; Chalmers K; Buxton J
Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):89-95. PubMed ID: 11815405
[TBL] [Abstract][Full Text] [Related]
14. Women's interest in gene expression analysis for breast cancer recurrence risk.
O'Neill SC; Brewer NT; Lillie SE; Morrill EF; Dees EC; Carey LA; Rimer BK
J Clin Oncol; 2007 Oct; 25(29):4628-34. PubMed ID: 17925559
[TBL] [Abstract][Full Text] [Related]
15. Women's interest in genetic testing for breast cancer susceptibility may be based on unrealistic expectations.
Press NA; Yasui Y; Reynolds S; Durfy SJ; Burke W
Am J Med Genet; 2001 Mar; 99(2):99-110. PubMed ID: 11241466
[TBL] [Abstract][Full Text] [Related]
16. Interest in genetic testing among first-degree relatives of breast cancer patients.
Lerman C; Seay J; Balshem A; Audrain J
Am J Med Genet; 1995 Jul; 57(3):385-92. PubMed ID: 7677139
[TBL] [Abstract][Full Text] [Related]
17. Psychosocial and Clinical Factors Associated with Family Communication of Cancer Genetic Test Results among Women Diagnosed with Breast Cancer at a Young Age.
Elrick A; Ashida S; Ivanovich J; Lyons S; Biesecker BB; Goodman MS; Kaphingst KA
J Genet Couns; 2017 Feb; 26(1):173-181. PubMed ID: 27422778
[TBL] [Abstract][Full Text] [Related]
18. Genetic testing for BRCA1: effects of a randomised study of knowledge provision on interest in testing and long term test uptake; implications for the NICE guidelines.
Hall J; Gray S; A'Hern R; Shanley S; Watson M; Kash K; Croyle R; Eeles R
Fam Cancer; 2009; 8(1):5-13. PubMed ID: 18679829
[TBL] [Abstract][Full Text] [Related]
19. "It wasn't just for me": Motivations and implications of genetic testing for women at a low risk of hereditary breast and ovarian cancer syndrome.
Gill G; Beard C; Storey K; Taylor S; Sexton A
Psychooncology; 2020 Aug; 29(8):1303-1311. PubMed ID: 32497346
[TBL] [Abstract][Full Text] [Related]
20. Cancer prevention and screening practices among women at risk for hereditary breast and ovarian cancer after genetic counseling in the community setting.
Morgan D; Sylvester H; Lucas FL; Miesfeldt S
Fam Cancer; 2009; 8(4):277-87. PubMed ID: 19347608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
